Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if rituximab is a safe and effective therapy for
steroid-refractory chronic graft versus host disease (GVHD).